
CAY10784
CAS No. 1245814-52-1
CAY10784( —— )
Catalog No. M34813 CAS No. 1245814-52-1
CAY10784 (STAT3-IN-17) is a STAT3 inhibitor with antiproliferative and antitumor activities. CAY10784 showed antibacterial activity against Clostridium difficile.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 90 | Get Quote |
![]() ![]() |
5MG | 202 | Get Quote |
![]() ![]() |
10MG | 353 | Get Quote |
![]() ![]() |
25MG | 724 | Get Quote |
![]() ![]() |
50MG | 1159 | Get Quote |
![]() ![]() |
100MG | 1782 | Get Quote |
![]() ![]() |
200MG | 2457 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCAY10784
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY10784 (STAT3-IN-17) is a STAT3 inhibitor with antiproliferative and antitumor activities. CAY10784 showed antibacterial activity against Clostridium difficile.
-
DescriptionSTAT3-IN-17 is a moderate STAT3 inhibitor (IC50=0.7 μM; HEK-Blue IL-6), with antiproliferative activity in HeLa cells. STAT3-IN-17 has good pharmacokinetic characteristics. STAT3-IN-17 also inhibits pyruvate-ferredoxin oxidoreductase (PFOR), and inhibits Helicobacter pylori.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1245814-52-1
-
Formula Weight317.24
-
Molecular FormulaC11H6F3N3O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC=C(C(F)(F)F)C=C1)NC2=NC=C([N+]([O-])=O)S2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lü Z, et al. Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors. ACS Med Chem Lett. 2021 Apr 1;12(5):696-703. ?
molnova catalog



related products
-
Methyl L-histidinate...
Inhibition of histidine decarboxylase in Sprague-Dawley rat stomach assessed as decrease in 14CO2 production with activty value of 1.8 μM
-
QD 232
QD 232 is a novel quinazolinedione-based redox modulator that potently inhibits Src/FAK and STAT3 phosphorylation.
-
Totrombopag
Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.